AiCure and The IMA Group Partner to Optimize Clinical Trial Recruitment and Patient Engagement IMA Clinical Research, a division of The IMA Group, will equip patients with AiCure's patient engagement solution to observe health management in a non-trial setting, advancing future trial recruitment criteria News provided by Share this article NEW YORK, March 15, 2021 /PRNewswire/ -- AiCure, an AI and data analytics company focused on improving clinical trials, and IMA, a national leader in providing clinical evaluation and research services, today announced a partnership to gain a widespread understanding of patient behavior and drug compliance outside of a clinical trial setting. With a database of over 300,000 potential subjects, IMA will roll out AiCure's patient engagement solution, Patient Connect, to study participants, offering patients convenient and enhanced support to successfully manage their existing treatment at home. This data will ultimately give sponsors access to a diverse pool of patients with known adherence patterns across therapeutic areas that could be recruited for upcoming trials, improving the likelihood of a trial's success and collection of high-quality data.